Curative Ventures V LLC — Form D/A
Curative Ventures V LLC of DALLAS, TX, a pooled investment fund, filed a Form D amendment with the SEC on 2021-03-26. The offering totals $74.0M, of which $74.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2021-03-26
- Form: D/A
- Accession: 0001754072-21-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Total offering: $74.0M
- Amount sold: $74.0M
- Investors: 23
- Date of first sale: 2018-09-10
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-322153
Issuer
- Name: Curative Ventures V LLC
- CIK: 0001754072
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 3963 MAPLE AVENUE, DALLAS, TX, 75219
- Phone: 972-979-7800
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| n/a CV-Immetacyte Manager LP | Executive Officer | Dallas, TX |
| [entity] CV-Immetacyte Manager LP | Executive Officer | Dallas, TX |
Other filings by this issuer (1)
More